99mTc-HMPAO标记白细胞SPECT/CT对心脏装置相关感染性心内膜炎的预后价值
前瞻性单中心研究纳入103例疑似心脏装置相关感染性心内膜炎患者,均行99mTc-HMPAO-SPECT/CT,按装置电极心脏段和血管段有无异常放射性摄取分为阳性组(35例)和阴性组(68例),平均随访17.48±11.9个月。阳性组院内死亡率、并发症发生率和硬件移除率均高于阴性组,全因死亡率有升高趋势但未达统计学显著。
要点
- 99mTc-HMPAO-SPECT/CT阳性提示院内死亡和并发症风险升高。
- 阳性组并发症发生率43% vs 阴性组9%(HR 5.9,95%CI 2.27–15.20)。
- 阳性组硬件移除更常见(57% vs 16%,HR 4.3,95%CI 2.07–19.08)。
关键影像表现/征象
- 扫描阳性定义为装置电极心脏段和血管段出现异常放射性摄取。
诊断标准与关键数值
- 阳性组35例,阴性组68例。
- 全因死亡率阳性组20% vs 阴性组10.3%(p=0.14),差异未达统计学显著。
- 院内死亡率阳性组11.4% vs 阴性组0%(OR 19.6,95%CI 1.02–374.70)。
- 并发症发生率阳性组43% vs 阴性组9%(HR 5.9,95%CI 2.27–15.20)。
- 硬件移除率阳性组57% vs 阴性组16%(HR 4.3,95%CI 2.07–19.08)。
临床应用与阅片要点
- 疑似心脏装置相关感染性心内膜炎患者行99mTc-HMPAO-SPECT/CT,阳性结果提示院内死亡和并发症风险升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This was a prospective, single-center study designed to assess the prognostic value of the hybrid technique of single photon emission tomography and computed tomography with the application of technetium99m-hexamethylpropyleneamine oxime-labelled autologous leukocytes (99mTc-HMPAO-SPECT/CT) in patients with cardiac device-related infective endocarditis (CDRIE).
BACKGROUND: CDRIE entails the risk of complications and an increase in mortality rates, both in-hospital and long-term. The prognostic value of 99mTc-HMPAO-SPECT/CT in the course of CDRIE has not been evaluated so far.
METHODS: The project enrolled 103 consecutive patients with suspected CDRIE, all of whom underwent 99mTc-HMPAO-SPECT/CT. The resulting scans were then classified as positive if the presence of abnormal tracer uptake involving cardiac and intravascular sections of the device electrodes was found. Patients were prospectively observed for a mean time of 17.48 ± 11.9 months. All-cause mortality, in-hospital mortality, and complete hardware removal were assessed, followed by a composite endpoint including complications, namely embolic events, new onset heart failure, uncontrolled infection, renal replacement therapy, reoperation, new heart rhythm, and conduction disturbances.
RESULTS: In the analysis, despite a noticeable trend, all-cause mortality rates were not found to be statistically significantly higher among the 35 patients who registered positive results using 99mTc-HMPAO-SPECT/CT for CDRIE (group 1) than among the 68 patients from group 2 whose 99mTc-HMPAO-SPECT/CT results were negative (20% vs. 10.3%, respectively; p = 0.14). However, group 1 did present higher in-hospital mortality (11.4% vs. 0%, respectively; odds ratio: 19.6; 95% confidence interval [CI]: 1.02 to 374.70), an increased rate of complications (43% vs. 9%, respectively; hazard ratio [HR]: 5.9; 95% CI: 2.27 to 15.20), and underwent hardware removal more frequently (57% vs. 16%, respectively; HR: 4.3; 95% CI: 2.07 to 19.08).
CONCLUSIONS: In patients with suspected CDRIE, positive 99mTc-HMPAO-SPECT/CT results were associated with increased rates of in-hospital mortality and complications.
引用
- Holcman K, Rubiś P, Ząbek A, et al. The Prognostic Value of 99mTc-HMPAO-Labeled Leucocyte SPECT/CT in Cardiac Device-Related Infective Endocarditis. JACC Cardiovasc Imaging. 2020. PMID: 32305467. doi:10.1016/j.jcmg.2020.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。